Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death
The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3‐kinase (PI3K)/Akt pathway in the development of chemoresistance in gastric cancer. In the present study, elevated Akt expression and Akt phosp...
Gespeichert in:
| Veröffentlicht in: | International journal of cancer 2008-01, Vol.122 (2), p.433-443 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 443 |
|---|---|
| container_issue | 2 |
| container_start_page | 433 |
| container_title | International journal of cancer |
| container_volume | 122 |
| creator | Yu, Hong‐Gang Ai, Yao‐Wei Yu, Liang‐Liang Zhou, Xiao‐Dong Liu, Jin Li, Jun‐Hua Xu, Xi‐Ming Liu, Song Chen, Jing Liu, Fen Qi, Yuan‐Ling Deng, Quanjun Cao, Jun Liu, Shi‐Quan Luo, He‐Sheng Yu, Jie‐Ping |
| description | The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3‐kinase (PI3K)/Akt pathway in the development of chemoresistance in gastric cancer. In the present study, elevated Akt expression and Akt phosphorylation (Ser 473), as well as decreased PTEN expression were observed in 28 cases of gastric cancer tissues. Etoposide and doxorubicin stimulated Akt and PI3K activities in 2 gastric cancer cell lines (BGC‐823 and SGC‐7901), and the activities were concentration and time‐dependent. Up‐regulation of PTEN expression in BGC‐823 cells by PEAK8‐PTEN transient transfection obviously decreased the basal and anticancer drugs induced Akt activities, then sensitized BGC‐823 cells to etoposide and doxorubicin. Pretreatment of BGC‐823 and SGC‐7901 cells with wortmannin, a PI3K inhibitor, attenuated cells's resistance to etoposide and doxorubicin. In addition, pretreatment of wortmannin blocked etoposide and doxorubicin induced IkappaB‐α degradation, NFkappaB activation, phosphorylation of Akt, MDM‐2 and forkhead transcription factors. Wortmannin pretreatment also promoted the accumulation of p27/Kip, but inhibited the Mcl‐1 expression. Furthermore, wortmannin promoted etoposide and doxorubicin induced caspase‐3, caspase‐9 activation and poly ADP‐ribose polymerase cleavage. Taken together, the observations indicate the PI3K/Akt pathway plays an important role in the chemoresistance of gastric cancer cells. A new strategy for combined chemotherapy of gastric cancer should be designed to more specifically block PI3K/Akt pathway and then decrease the amount of resistant cells. © 2007 Wiley‐Liss, Inc. |
| doi_str_mv | 10.1002/ijc.23049 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70084936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20619257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4509-6aaa7f329530c054c05dab1f2fab01744ce41d7a952c7482ae77a93571c8bbc83</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi1ERZfCgRdAvlCJQ7pjO4nXx2oFpahSOcA5mthO120SB9tR2VsfgTfou_EkeLsr9YQ4WCPPfP7_kX9C3jE4YwB86W71GRdQqhdkwUDJAjirXpJFnkEhmaiPyesYbwEYq6B8RY6ZVKJiQi7I47eNj9PGu9FHl5yxVPx5-H3nRox2eX6X6IRpc49bOvW4jRRH6obJh4RjosH3lrqR6o0dfLDRxdzWlvqO3mBMwWmqd41Ate37_PgG3RgTtclP2S174Wio8b98mFuns5IbzayteeKpsdn6DTnqsI_27aGekB-fP31ffymuri8u1-dXhS4rUEWNiLITXFUCNFRlPgZb1vEOW2CyLLUtmZGoKq5lueJoZb6ISjK9alu9EifkdK87Bf9ztjE1g4u7NXC0fo6NBFiVStT_BTnUTPFKZvDjHtTBxxhs10zBDRi2DYNmF1uTY2ueYsvs-4Po3A7WPJOHnDLw4QBg1Nh3If-ri8-cUsCg3gkt99y96-32347N5df13vovQpGykw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20619257</pqid></control><display><type>article</type><title>Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Yu, Hong‐Gang ; Ai, Yao‐Wei ; Yu, Liang‐Liang ; Zhou, Xiao‐Dong ; Liu, Jin ; Li, Jun‐Hua ; Xu, Xi‐Ming ; Liu, Song ; Chen, Jing ; Liu, Fen ; Qi, Yuan‐Ling ; Deng, Quanjun ; Cao, Jun ; Liu, Shi‐Quan ; Luo, He‐Sheng ; Yu, Jie‐Ping</creator><creatorcontrib>Yu, Hong‐Gang ; Ai, Yao‐Wei ; Yu, Liang‐Liang ; Zhou, Xiao‐Dong ; Liu, Jin ; Li, Jun‐Hua ; Xu, Xi‐Ming ; Liu, Song ; Chen, Jing ; Liu, Fen ; Qi, Yuan‐Ling ; Deng, Quanjun ; Cao, Jun ; Liu, Shi‐Quan ; Luo, He‐Sheng ; Yu, Jie‐Ping</creatorcontrib><description>The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3‐kinase (PI3K)/Akt pathway in the development of chemoresistance in gastric cancer. In the present study, elevated Akt expression and Akt phosphorylation (Ser 473), as well as decreased PTEN expression were observed in 28 cases of gastric cancer tissues. Etoposide and doxorubicin stimulated Akt and PI3K activities in 2 gastric cancer cell lines (BGC‐823 and SGC‐7901), and the activities were concentration and time‐dependent. Up‐regulation of PTEN expression in BGC‐823 cells by PEAK8‐PTEN transient transfection obviously decreased the basal and anticancer drugs induced Akt activities, then sensitized BGC‐823 cells to etoposide and doxorubicin. Pretreatment of BGC‐823 and SGC‐7901 cells with wortmannin, a PI3K inhibitor, attenuated cells's resistance to etoposide and doxorubicin. In addition, pretreatment of wortmannin blocked etoposide and doxorubicin induced IkappaB‐α degradation, NFkappaB activation, phosphorylation of Akt, MDM‐2 and forkhead transcription factors. Wortmannin pretreatment also promoted the accumulation of p27/Kip, but inhibited the Mcl‐1 expression. Furthermore, wortmannin promoted etoposide and doxorubicin induced caspase‐3, caspase‐9 activation and poly ADP‐ribose polymerase cleavage. Taken together, the observations indicate the PI3K/Akt pathway plays an important role in the chemoresistance of gastric cancer cells. A new strategy for combined chemotherapy of gastric cancer should be designed to more specifically block PI3K/Akt pathway and then decrease the amount of resistant cells. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.23049</identifier><identifier>PMID: 17935137</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Akt ; Antineoplastic agents ; Antineoplastic Agents - pharmacology ; Apoptosis ; Biological and medical sciences ; Cell Line, Tumor ; Chemotherapy ; Doxorubicin - pharmacology ; Drug Resistance, Neoplasm ; Enzyme Activation ; Enzyme Inhibitors - pharmacology ; Etoposide - pharmacology ; gastric cancer ; Humans ; I-kappa B Proteins - metabolism ; Medical sciences ; NF-kappa B - metabolism ; NF-KappaB Inhibitor alpha ; Pharmacology. Drug treatments ; Phosphatidylinositol 3-Kinases - metabolism ; phosphoinositide 3‐kinase ; Poly(ADP-ribose) Polymerases - metabolism ; Proto-Oncogene Proteins c-akt - metabolism ; Stomach Neoplasms - drug therapy ; Stomach Neoplasms - enzymology ; Transfection ; Tumors</subject><ispartof>International journal of cancer, 2008-01, Vol.122 (2), p.433-443</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>2008 INIST-CNRS</rights><rights>Copyright 2007 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4509-6aaa7f329530c054c05dab1f2fab01744ce41d7a952c7482ae77a93571c8bbc83</citedby><cites>FETCH-LOGICAL-c4509-6aaa7f329530c054c05dab1f2fab01744ce41d7a952c7482ae77a93571c8bbc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fijc.23049$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fijc.23049$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1413,27906,27907,45556,45557</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19901069$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17935137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Hong‐Gang</creatorcontrib><creatorcontrib>Ai, Yao‐Wei</creatorcontrib><creatorcontrib>Yu, Liang‐Liang</creatorcontrib><creatorcontrib>Zhou, Xiao‐Dong</creatorcontrib><creatorcontrib>Liu, Jin</creatorcontrib><creatorcontrib>Li, Jun‐Hua</creatorcontrib><creatorcontrib>Xu, Xi‐Ming</creatorcontrib><creatorcontrib>Liu, Song</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Liu, Fen</creatorcontrib><creatorcontrib>Qi, Yuan‐Ling</creatorcontrib><creatorcontrib>Deng, Quanjun</creatorcontrib><creatorcontrib>Cao, Jun</creatorcontrib><creatorcontrib>Liu, Shi‐Quan</creatorcontrib><creatorcontrib>Luo, He‐Sheng</creatorcontrib><creatorcontrib>Yu, Jie‐Ping</creatorcontrib><title>Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3‐kinase (PI3K)/Akt pathway in the development of chemoresistance in gastric cancer. In the present study, elevated Akt expression and Akt phosphorylation (Ser 473), as well as decreased PTEN expression were observed in 28 cases of gastric cancer tissues. Etoposide and doxorubicin stimulated Akt and PI3K activities in 2 gastric cancer cell lines (BGC‐823 and SGC‐7901), and the activities were concentration and time‐dependent. Up‐regulation of PTEN expression in BGC‐823 cells by PEAK8‐PTEN transient transfection obviously decreased the basal and anticancer drugs induced Akt activities, then sensitized BGC‐823 cells to etoposide and doxorubicin. Pretreatment of BGC‐823 and SGC‐7901 cells with wortmannin, a PI3K inhibitor, attenuated cells's resistance to etoposide and doxorubicin. In addition, pretreatment of wortmannin blocked etoposide and doxorubicin induced IkappaB‐α degradation, NFkappaB activation, phosphorylation of Akt, MDM‐2 and forkhead transcription factors. Wortmannin pretreatment also promoted the accumulation of p27/Kip, but inhibited the Mcl‐1 expression. Furthermore, wortmannin promoted etoposide and doxorubicin induced caspase‐3, caspase‐9 activation and poly ADP‐ribose polymerase cleavage. Taken together, the observations indicate the PI3K/Akt pathway plays an important role in the chemoresistance of gastric cancer cells. A new strategy for combined chemotherapy of gastric cancer should be designed to more specifically block PI3K/Akt pathway and then decrease the amount of resistant cells. © 2007 Wiley‐Liss, Inc.</description><subject>Akt</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Cell Line, Tumor</subject><subject>Chemotherapy</subject><subject>Doxorubicin - pharmacology</subject><subject>Drug Resistance, Neoplasm</subject><subject>Enzyme Activation</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Etoposide - pharmacology</subject><subject>gastric cancer</subject><subject>Humans</subject><subject>I-kappa B Proteins - metabolism</subject><subject>Medical sciences</subject><subject>NF-kappa B - metabolism</subject><subject>NF-KappaB Inhibitor alpha</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>phosphoinositide 3‐kinase</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Stomach Neoplasms - enzymology</subject><subject>Transfection</subject><subject>Tumors</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi1ERZfCgRdAvlCJQ7pjO4nXx2oFpahSOcA5mthO120SB9tR2VsfgTfou_EkeLsr9YQ4WCPPfP7_kX9C3jE4YwB86W71GRdQqhdkwUDJAjirXpJFnkEhmaiPyesYbwEYq6B8RY6ZVKJiQi7I47eNj9PGu9FHl5yxVPx5-H3nRox2eX6X6IRpc49bOvW4jRRH6obJh4RjosH3lrqR6o0dfLDRxdzWlvqO3mBMwWmqd41Ate37_PgG3RgTtclP2S174Wio8b98mFuns5IbzayteeKpsdn6DTnqsI_27aGekB-fP31ffymuri8u1-dXhS4rUEWNiLITXFUCNFRlPgZb1vEOW2CyLLUtmZGoKq5lueJoZb6ISjK9alu9EifkdK87Bf9ztjE1g4u7NXC0fo6NBFiVStT_BTnUTPFKZvDjHtTBxxhs10zBDRi2DYNmF1uTY2ueYsvs-4Po3A7WPJOHnDLw4QBg1Nh3If-ri8-cUsCg3gkt99y96-32347N5df13vovQpGykw</recordid><startdate>20080115</startdate><enddate>20080115</enddate><creator>Yu, Hong‐Gang</creator><creator>Ai, Yao‐Wei</creator><creator>Yu, Liang‐Liang</creator><creator>Zhou, Xiao‐Dong</creator><creator>Liu, Jin</creator><creator>Li, Jun‐Hua</creator><creator>Xu, Xi‐Ming</creator><creator>Liu, Song</creator><creator>Chen, Jing</creator><creator>Liu, Fen</creator><creator>Qi, Yuan‐Ling</creator><creator>Deng, Quanjun</creator><creator>Cao, Jun</creator><creator>Liu, Shi‐Quan</creator><creator>Luo, He‐Sheng</creator><creator>Yu, Jie‐Ping</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20080115</creationdate><title>Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death</title><author>Yu, Hong‐Gang ; Ai, Yao‐Wei ; Yu, Liang‐Liang ; Zhou, Xiao‐Dong ; Liu, Jin ; Li, Jun‐Hua ; Xu, Xi‐Ming ; Liu, Song ; Chen, Jing ; Liu, Fen ; Qi, Yuan‐Ling ; Deng, Quanjun ; Cao, Jun ; Liu, Shi‐Quan ; Luo, He‐Sheng ; Yu, Jie‐Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4509-6aaa7f329530c054c05dab1f2fab01744ce41d7a952c7482ae77a93571c8bbc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Akt</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Cell Line, Tumor</topic><topic>Chemotherapy</topic><topic>Doxorubicin - pharmacology</topic><topic>Drug Resistance, Neoplasm</topic><topic>Enzyme Activation</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Etoposide - pharmacology</topic><topic>gastric cancer</topic><topic>Humans</topic><topic>I-kappa B Proteins - metabolism</topic><topic>Medical sciences</topic><topic>NF-kappa B - metabolism</topic><topic>NF-KappaB Inhibitor alpha</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>phosphoinositide 3‐kinase</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Stomach Neoplasms - enzymology</topic><topic>Transfection</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Hong‐Gang</creatorcontrib><creatorcontrib>Ai, Yao‐Wei</creatorcontrib><creatorcontrib>Yu, Liang‐Liang</creatorcontrib><creatorcontrib>Zhou, Xiao‐Dong</creatorcontrib><creatorcontrib>Liu, Jin</creatorcontrib><creatorcontrib>Li, Jun‐Hua</creatorcontrib><creatorcontrib>Xu, Xi‐Ming</creatorcontrib><creatorcontrib>Liu, Song</creatorcontrib><creatorcontrib>Chen, Jing</creatorcontrib><creatorcontrib>Liu, Fen</creatorcontrib><creatorcontrib>Qi, Yuan‐Ling</creatorcontrib><creatorcontrib>Deng, Quanjun</creatorcontrib><creatorcontrib>Cao, Jun</creatorcontrib><creatorcontrib>Liu, Shi‐Quan</creatorcontrib><creatorcontrib>Luo, He‐Sheng</creatorcontrib><creatorcontrib>Yu, Jie‐Ping</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Hong‐Gang</au><au>Ai, Yao‐Wei</au><au>Yu, Liang‐Liang</au><au>Zhou, Xiao‐Dong</au><au>Liu, Jin</au><au>Li, Jun‐Hua</au><au>Xu, Xi‐Ming</au><au>Liu, Song</au><au>Chen, Jing</au><au>Liu, Fen</au><au>Qi, Yuan‐Ling</au><au>Deng, Quanjun</au><au>Cao, Jun</au><au>Liu, Shi‐Quan</au><au>Luo, He‐Sheng</au><au>Yu, Jie‐Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2008-01-15</date><risdate>2008</risdate><volume>122</volume><issue>2</issue><spage>433</spage><epage>443</epage><pages>433-443</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>The major obstacle to successful treatment of gastric cancer is chemotherapy resistance. Our study was designed to investigate the role of phosphoinositide 3‐kinase (PI3K)/Akt pathway in the development of chemoresistance in gastric cancer. In the present study, elevated Akt expression and Akt phosphorylation (Ser 473), as well as decreased PTEN expression were observed in 28 cases of gastric cancer tissues. Etoposide and doxorubicin stimulated Akt and PI3K activities in 2 gastric cancer cell lines (BGC‐823 and SGC‐7901), and the activities were concentration and time‐dependent. Up‐regulation of PTEN expression in BGC‐823 cells by PEAK8‐PTEN transient transfection obviously decreased the basal and anticancer drugs induced Akt activities, then sensitized BGC‐823 cells to etoposide and doxorubicin. Pretreatment of BGC‐823 and SGC‐7901 cells with wortmannin, a PI3K inhibitor, attenuated cells's resistance to etoposide and doxorubicin. In addition, pretreatment of wortmannin blocked etoposide and doxorubicin induced IkappaB‐α degradation, NFkappaB activation, phosphorylation of Akt, MDM‐2 and forkhead transcription factors. Wortmannin pretreatment also promoted the accumulation of p27/Kip, but inhibited the Mcl‐1 expression. Furthermore, wortmannin promoted etoposide and doxorubicin induced caspase‐3, caspase‐9 activation and poly ADP‐ribose polymerase cleavage. Taken together, the observations indicate the PI3K/Akt pathway plays an important role in the chemoresistance of gastric cancer cells. A new strategy for combined chemotherapy of gastric cancer should be designed to more specifically block PI3K/Akt pathway and then decrease the amount of resistant cells. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17935137</pmid><doi>10.1002/ijc.23049</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0020-7136 |
| ispartof | International journal of cancer, 2008-01, Vol.122 (2), p.433-443 |
| issn | 0020-7136 1097-0215 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70084936 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Akt Antineoplastic agents Antineoplastic Agents - pharmacology Apoptosis Biological and medical sciences Cell Line, Tumor Chemotherapy Doxorubicin - pharmacology Drug Resistance, Neoplasm Enzyme Activation Enzyme Inhibitors - pharmacology Etoposide - pharmacology gastric cancer Humans I-kappa B Proteins - metabolism Medical sciences NF-kappa B - metabolism NF-KappaB Inhibitor alpha Pharmacology. Drug treatments Phosphatidylinositol 3-Kinases - metabolism phosphoinositide 3‐kinase Poly(ADP-ribose) Polymerases - metabolism Proto-Oncogene Proteins c-akt - metabolism Stomach Neoplasms - drug therapy Stomach Neoplasms - enzymology Transfection Tumors |
| title | Phosphoinositide 3‐kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T11%3A31%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phosphoinositide%203%E2%80%90kinase/Akt%20pathway%20plays%20an%20important%20role%20in%20chemoresistance%20of%20gastric%20cancer%20cells%20against%20etoposide%20and%20doxorubicin%20induced%20cell%20death&rft.jtitle=International%20journal%20of%20cancer&rft.au=Yu,%20Hong%E2%80%90Gang&rft.date=2008-01-15&rft.volume=122&rft.issue=2&rft.spage=433&rft.epage=443&rft.pages=433-443&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/ijc.23049&rft_dat=%3Cproquest_cross%3E20619257%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20619257&rft_id=info:pmid/17935137&rfr_iscdi=true |